ProfileGDS4718 / 203343_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 99% 95% 99% 99% 92% 94% 99% 97% 99% 99% 98% 97% 92% 96% 97% 98% 93% 95% 97% 99% 98% 98% 98% 98% 93% 98% 96% 99% 96% 97% 94% 99% 99% 91% 92% 96% 98% 98% 91% 99% 94% 97% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.925398
GSM549102patient 115, normal, homogenized [OPG study]12.117399
GSM549104patient 119, normal, homogenized [OPG study]10.232195
GSM549108patient 138, normal, homogenized [OPG study]11.864699
GSM549119patient 077, normal, homogenized [OPG study]12.191899
GSM549133patient 032, cancer, homogenized [OPG study]9.6424192
GSM549139patient 042, cancer, homogenized [OPG study]9.9281894
GSM549099patient 107, normal, homogenized [OPG study]11.890999
GSM549109patient 139, normal, homogenized [OPG study]11.097297
GSM549110patient 046, normal, homogenized [OPG study]12.069699
GSM549114patient 063, normal, homogenized [OPG study]12.642199
GSM549122patient 082, normal, homogenized [OPG study]11.331198
GSM549134patient 033, cancer, homogenized [OPG study]10.88497
GSM549136patient 036, cancer, homogenized [OPG study]9.6228492
GSM549140patient 044, cancer, homogenized [OPG study]10.619696
GSM549111patient 047, normal, homogenized [OPG study]11.303597
GSM549113patient 057, normal, homogenized [OPG study]11.730398
GSM549132patient 031, cancer, homogenized [OPG study]9.6047593
GSM549137patient 038, cancer, homogenized [OPG study]10.218895
GSM549142patient 047, cancer, homogenized [OPG study]10.253297
GSM549100patient 110, normal, homogenized [OPG study]11.954299
GSM549107patient 135, normal, homogenized [OPG study]11.907998
GSM549115patient 068, normal, homogenized [OPG study]11.837698
GSM549116patient 072, normal, homogenized [OPG study]11.937398
GSM549120patient 078, normal, homogenized [OPG study]11.840798
GSM549131patient 030, cancer, homogenized [OPG study]9.8175193
GSM549118patient 074, normal, homogenized [OPG study]11.645598
GSM549129patient 027, cancer, homogenized [OPG study]10.204396
GSM549123patient 088, normal, homogenized [OPG study]12.003199
GSM549124patient 006, cancer, homogenized [OPG study]10.177596
GSM549126patient 015, cancer, homogenized [OPG study]10.694497
GSM549128patient 025, cancer, homogenized [OPG study]10.032394
GSM549103patient 117, normal, homogenized [OPG study]12.087699
GSM549117patient 073, normal, homogenized [OPG study]12.104199
GSM549138patient 041, cancer, homogenized [OPG study]9.4388891
GSM549141patient 045, cancer, homogenized [OPG study]9.6464892
GSM549130patient 028, cancer, homogenized [OPG study]10.213596
GSM549101patient 111, normal, homogenized [OPG study]11.590498
GSM549105patient 128, normal, homogenized [OPG study]11.769698
GSM549106patient 134, normal, homogenized [OPG study]9.5672191
GSM549112patient 048, normal, homogenized [OPG study]12.103499
GSM549125patient 011, cancer, homogenized [OPG study]9.8296794
GSM549127patient 024, cancer, homogenized [OPG study]10.573397
GSM549135patient 035, cancer, homogenized [OPG study]9.0525589